4943-83-3,MFCD03425820
Catalog No.:AA00D8Q3

4943-83-3 | 2-Amino-n-(2-propynyl)benzenecarboxamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
in stock  
$202.00   $142.00
- +
1g
in stock  
$288.00   $202.00
- +
5g
in stock  
$747.00   $523.00
- +
10g
in stock  
$1,205.00   $844.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00D8Q3
Chemical Name:
2-Amino-n-(2-propynyl)benzenecarboxamide
CAS Number:
4943-83-3
Molecular Formula:
C10H10N2O
Molecular Weight:
174.1992
MDL Number:
MFCD03425820
SMILES:
C#CCNC(=O)c1ccccc1N
Properties
Computed Properties
 
Complexity:
228  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.7  

Downstream Synthesis Route

[1]Weinberg,LindaR.;Albom,MarkS.;Angeles,ThelmaS.;Husten,Jean;Lisko,JosephG.;McHugh,RobertJ.;Milkiewicz,KarenL.;Murthy,Seetha;Ott,GregoryR.;Theroff,JayP.;Tripathy,Rabindranath;Underiner,TedL.;Zificsak,CraigA.;Dorsey,BruceD.[BioorganicandMedicinalChemistryLetters,2011,vol.21,#1,p.164-167]

[2]Tseng,Ming-Chung;Chu,Yu-Wan;Tsai,Hsiang-Ping;Lin,Chun-Mao;Hwang,Jaulang;Chu,Yen-Ho[OrganicLetters,2011,vol.13,#5,p.920-923]

[3]Usifoh;Edema[SouthAfricanJournalofChemistry,2000,vol.53,#2,p.47-48]

[4]CurrentPatentAssignee:GUANGXINORMALUNIVERSITY-CN113480537,2021,ALocationinpatent:Paragraph0054-0057;0141-0144

[5]Usifoh,CyrilO.;Scriba,GerhardK.E.[ArchivderPharmazie,2000,vol.333,#8,p.261-266]

[6]Głowacka,IwonaE.;Grzonkowski,Piotr;Lisiecki,Paweł;Kalinowski,Łukasz;Piotrowska,DorotaG.[ArchivderPharmazie,2019,vol.352,#3]

[7]Twin,Heather;Batey,RobertA.[OrganicLetters,2004,vol.6,#26,p.4913-4916]

[8]CurrentPatentAssignee:CERTATHERAPEUTICS-WO2008/3141,2008,A1Locationinpatent:Page/Pagecolumn53-54

[9]Eloy;Deryckere[Chimicatherapeutica,1973,vol.8,#4,p.437-446]

[10]Ojeikere,Odafenkhoa;Usifoh,Cyril;Ebeigbe,Anthony[ScientiaPharmaceutica,2003,vol.71,#4,p.321-329]

[11]Senadi,GopalChandru;Hu,Wan-Ping;Hsiao,Jia-Shing;Vandavasi,JayaKishore;Chen,Chung-Yu;Wang,Jeh-Jeng[OrganicLetters,2012,vol.14,#17,p.4478-4481]

[12]Esmaeili-Marandi,Fatemeh;Saeedi,Mina;Yavari,Issa;Mahdavi,Mohammad;Shafiee,Abbas[HelveticaChimicaActa,2016,vol.99,#1,p.37-40]

[13]Farjadmand,Fatemeh;Arshadi,Hossein;Moghimi,Setareh;Nadri,Hamid;Moradi,Alireza;Eghtedari,Mohammad;Jafarpour,Farnaz;Mahdavi,Mohammad;Shafiee,Abbas;Foroumadi,Alireza[JournalofChemicalResearch,2016,vol.40,#3,p.188-191]

[14]Moghimi,Setareh;Goli-Garmroodi,Fereshteh;Pilali,Hedieh;Mahdavi,Mohammad;Firoozpour,Loghman;Nadri,Hamid;Moradi,Alireza;Asadipour,Ali;Shafiee,Abbas;Foroumadi,Alireza[JournalofChemicalSciences,2016,vol.128,#9,p.1445-1449]

[15]Kong,Xiang-Fei;Zhan,Feng;He,Guo-Xue;Pan,Cheng-Xue;Gu,Chen-Xi;Lu,Ke;Mo,Dong-Liang;Su,Gui-Fa[JournalofOrganicChemistry,2018,vol.83,#4,p.2006-2017]

[16]Senadi,GopalChandru;Kudale,VishalSuresh;Wang,Jeh-Jeng[GreenChemistry,2019,vol.21,#5,p.979-985]

[1]Reisch,J.;Usifoh,C.O.;Oluwadiya,J.O.[JournalofHeterocyclicChemistry,1990,vol.27,#7,p.1953-1956]

[2]Ojeikere,Odafenkhoa;Usifoh,Cyril;Ebeigbe,Anthony[ScientiaPharmaceutica,2003,vol.71,#4,p.321-329]

[1]Reisch,J.;Usifoh,C.O.;Oluwadiya,J.O.[JournalofHeterocyclicChemistry,1990,vol.27,#7,p.1953-1956]

[2]Usifoh,CyrilO.;Scriba,GerhardK.E.[ArchivderPharmazie,2000,vol.333,#8,p.261-266]

[3]Głowacka,IwonaE.;Grzonkowski,Piotr;Lisiecki,Paweł;Kalinowski,Łukasz;Piotrowska,DorotaG.[ArchivderPharmazie,2019,vol.352,#3]

[1]Twin,Heather;Batey,RobertA.[OrganicLetters,2004,vol.6,#26,p.4913-4916]

(E)-3,4-dimethoxycinnamicchloride 
  4943-83-3   
(E)-2-3-(3,4-dimethoxyphenyl)-1-oxo-2-propenylamino-N-propargylbenzamide 

[1]CurrentPatentAssignee:CERTATHERAPEUTICS-WO2008/3141,2008,A1Locationinpatent:Page/Pagecolumn54

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 4943-83-3
Historical Records
Tags:4943-83-3 Molecular Formula|4943-83-3 MDL|4943-83-3 SMILES|4943-83-3 2-Amino-n-(2-propynyl)benzenecarboxamide
Catalog No.: AA00D8Q3
4943-83-3,MFCD03425820
4943-83-3 | 2-Amino-n-(2-propynyl)benzenecarboxamide
Pack Size: 500mg
Purity:
in stock
$202.00 $142.00
Pack Size: 1g
Purity:
in stock
$288.00 $202.00
Pack Size: 5g
Purity:
in stock
$747.00 $523.00
Pack Size: 10g
Purity:
in stock
$1,205.00 $844.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00D8Q3
Chemical Name: 2-Amino-n-(2-propynyl)benzenecarboxamide
CAS Number: 4943-83-3
Molecular Formula: C10H10N2O
Molecular Weight: 174.1992
MDL Number: MFCD03425820
SMILES: C#CCNC(=O)c1ccccc1N
Properties
Complexity: 228  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 13  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.7  
Downstream Synthesis Route
118-48-9    2450-71-7    4943-83-3 

[1]Weinberg,LindaR.;Albom,MarkS.;Angeles,ThelmaS.;Husten,Jean;Lisko,JosephG.;McHugh,RobertJ.;Milkiewicz,KarenL.;Murthy,Seetha;Ott,GregoryR.;Theroff,JayP.;Tripathy,Rabindranath;Underiner,TedL.;Zificsak,CraigA.;Dorsey,BruceD.[BioorganicandMedicinalChemistryLetters,2011,vol.21,#1,p.164-167]

[2]Tseng,Ming-Chung;Chu,Yu-Wan;Tsai,Hsiang-Ping;Lin,Chun-Mao;Hwang,Jaulang;Chu,Yen-Ho[OrganicLetters,2011,vol.13,#5,p.920-923]

[3]Usifoh;Edema[SouthAfricanJournalofChemistry,2000,vol.53,#2,p.47-48]

[4]CurrentPatentAssignee:GUANGXINORMALUNIVERSITY-CN113480537,2021,ALocationinpatent:Paragraph0054-0057;0141-0144

[5]Usifoh,CyrilO.;Scriba,GerhardK.E.[ArchivderPharmazie,2000,vol.333,#8,p.261-266]

[6]Głowacka,IwonaE.;Grzonkowski,Piotr;Lisiecki,Paweł;Kalinowski,Łukasz;Piotrowska,DorotaG.[ArchivderPharmazie,2019,vol.352,#3]

[7]Twin,Heather;Batey,RobertA.[OrganicLetters,2004,vol.6,#26,p.4913-4916]

[8]CurrentPatentAssignee:CERTATHERAPEUTICS-WO2008/3141,2008,A1Locationinpatent:Page/Pagecolumn53-54

[9]Eloy;Deryckere[Chimicatherapeutica,1973,vol.8,#4,p.437-446]

[10]Ojeikere,Odafenkhoa;Usifoh,Cyril;Ebeigbe,Anthony[ScientiaPharmaceutica,2003,vol.71,#4,p.321-329]

[11]Senadi,GopalChandru;Hu,Wan-Ping;Hsiao,Jia-Shing;Vandavasi,JayaKishore;Chen,Chung-Yu;Wang,Jeh-Jeng[OrganicLetters,2012,vol.14,#17,p.4478-4481]

[12]Esmaeili-Marandi,Fatemeh;Saeedi,Mina;Yavari,Issa;Mahdavi,Mohammad;Shafiee,Abbas[HelveticaChimicaActa,2016,vol.99,#1,p.37-40]

[13]Farjadmand,Fatemeh;Arshadi,Hossein;Moghimi,Setareh;Nadri,Hamid;Moradi,Alireza;Eghtedari,Mohammad;Jafarpour,Farnaz;Mahdavi,Mohammad;Shafiee,Abbas;Foroumadi,Alireza[JournalofChemicalResearch,2016,vol.40,#3,p.188-191]

[14]Moghimi,Setareh;Goli-Garmroodi,Fereshteh;Pilali,Hedieh;Mahdavi,Mohammad;Firoozpour,Loghman;Nadri,Hamid;Moradi,Alireza;Asadipour,Ali;Shafiee,Abbas;Foroumadi,Alireza[JournalofChemicalSciences,2016,vol.128,#9,p.1445-1449]

[15]Kong,Xiang-Fei;Zhan,Feng;He,Guo-Xue;Pan,Cheng-Xue;Gu,Chen-Xi;Lu,Ke;Mo,Dong-Liang;Su,Gui-Fa[JournalofOrganicChemistry,2018,vol.83,#4,p.2006-2017]

[16]Senadi,GopalChandru;Kudale,VishalSuresh;Wang,Jeh-Jeng[GreenChemistry,2019,vol.21,#5,p.979-985]

4943-83-3    78-39-7    23905-38-6 

[1]Reisch,J.;Usifoh,C.O.;Oluwadiya,J.O.[JournalofHeterocyclicChemistry,1990,vol.27,#7,p.1953-1956]

[2]Ojeikere,Odafenkhoa;Usifoh,Cyril;Ebeigbe,Anthony[ScientiaPharmaceutica,2003,vol.71,#4,p.321-329]

4943-83-3    122-51-0    16347-56-1 

[1]Reisch,J.;Usifoh,C.O.;Oluwadiya,J.O.[JournalofHeterocyclicChemistry,1990,vol.27,#7,p.1953-1956]

[2]Usifoh,CyrilO.;Scriba,GerhardK.E.[ArchivderPharmazie,2000,vol.333,#8,p.261-266]

[3]Głowacka,IwonaE.;Grzonkowski,Piotr;Lisiecki,Paweł;Kalinowski,Łukasz;Piotrowska,DorotaG.[ArchivderPharmazie,2019,vol.352,#3]

4943-83-3    13831-31-7    823235-08-1 

[1]Twin,Heather;Batey,RobertA.[OrganicLetters,2004,vol.6,#26,p.4913-4916]

(E)-3,4-dimethoxycinnamicchloride 
  4943-83-3   
(E)-2-3-(3,4-dimethoxyphenyl)-1-oxo-2-propenylamino-N-propargylbenzamide 

[1]CurrentPatentAssignee:CERTATHERAPEUTICS-WO2008/3141,2008,A1Locationinpatent:Page/Pagecolumn54

Building Blocks More >
5231-89-0
5231-89-0
3,4-Diaminocyclobut-3-ene-1,2-dione
AA00D8VC | MFCD00205212
5177-39-9
5177-39-9
7-Chloro-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-2,5-dione
AA00D91L | MFCD00024146
5368-42-3
5368-42-3
1,8-Dioxo-2,3,4,8-tetrahydro-1H-pyrido[1,2-a]pyrazine-6-carboxylic acid
AA00D97W | MFCD27966340
462068-45-7
462068-45-7
N-(4-AMINO-PHENYL)-3-MORPHOLIN-4-YL-PROPIONAMIDE
AA00D9E9 | MFCD02737888
52286-58-5
52286-58-5
Ginsenoside rf
AA00D9MB | MFCD00210509
5302-79-4
5302-79-4
7-Methoxynaphthalen-1-amine
AA00D9SG | MFCD08272073
54029-03-7
54029-03-7
Ethyl 5-(4-chlorophenyl)-5-oxovalerate
AA00D9YQ | MFCD01320184
5234-26-4
5234-26-4
N-(2-Acetyl-phenyl)-acetamide
AA00DA55 | MFCD00032277
53525-60-3
53525-60-3
Ethyl 1-trityl-1H-imidazole-4-carboxylate
AA00DA9S | MFCD01060879
468075-00-5
468075-00-5
2-Bromo-1-chloro-4-(trifluoromethoxy)benzene
AA00DAD1 | MFCD06797751
Submit
© 2017 AA BLOCKS, INC. All rights reserved.